Asarfi Hospital Ltd Stock Price Today (NSE: ASARFI)
Fundamental Score
Asarfi Hospital Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Asarfi Hospital Ltd share price today is ₹221.85, up +5.49% on NSE/BSE as of 7 August 2026. Asarfi Hospital Ltd (ASARFI) is a Small-cap company in the Hospital sector with a market capitalisation of ₹437.92 (Cr). The 52-week high for ASARFI share price is ₹256.95 and the 52-week low is ₹117.20. At a P/E ratio of 25.64x, ASARFI is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 18.98% and a debt-to-equity ratio of 0.58.
Asarfi Hospital Ltd Share Price Chart — NSE/BSE Historical Performance
Asarfi Hospital Ltd share price chart: -3.50% return over the past month. 52-week high ₹256.95, 52-week low ₹117.20.
Asarfi Hospital Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹212.00 | ₹223.85 | ₹211.40 | ₹221.85 | 55.00K (Cr) | |
| ₹207.45 | ₹212.95 | ₹207.45 | ₹210.30 | 24.00K (Cr) | |
| ₹205.85 | ₹207.95 | ₹203.25 | ₹205.50 | 22.00K (Cr) | |
| ₹208.50 | ₹208.50 | ₹196.00 | ₹201.80 | 97.00K (Cr) | |
| ₹205.00 | ₹214.00 | ₹203.00 | ₹212.75 | 20.00K (Cr) | |
| ₹208.00 | ₹210.20 | ₹204.00 | ₹206.90 | 17.00K (Cr) | |
| ₹209.00 | ₹211.00 | ₹208.00 | ₹210.30 | 11.00K (Cr) | |
| ₹212.40 | ₹212.40 | ₹206.85 | ₹208.60 | 13.00K (Cr) | |
| ₹210.20 | ₹213.25 | ₹210.20 | ₹212.85 | 8.00K (Cr) | |
| ₹213.05 | ₹218.00 | ₹213.05 | ₹213.75 | 12.00K (Cr) |
Asarfi Hospital Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹205.00 | ₹223.85 | ₹196.00 | ₹221.85 | +8.22% | |
| ₹220.00 | ₹230.00 | ₹204.00 | ₹206.90 | -5.95% | |
| ₹190.70 | ₹235.00 | ₹189.00 | ₹225.25 | +18.12% | |
| ₹216.90 | ₹256.95 | ₹180.00 | ₹190.70 | -12.08% | |
| ₹175.00 | ₹236.40 | ₹172.25 | ₹216.00 | +23.43% | |
| ₹156.00 | ₹188.80 | ₹147.70 | ₹169.55 | +8.69% | |
| ₹179.00 | ₹196.90 | ₹155.05 | ₹157.80 | -11.84% | |
| ₹185.00 | ₹190.00 | ₹154.85 | ₹181.55 | -1.86% | |
| ₹190.00 | ₹203.15 | ₹176.00 | ₹188.10 | -1.00% | |
| ₹150.00 | ₹221.00 | ₹135.00 | ₹199.60 | +33.07% | |
| ₹129.00 | ₹168.00 | ₹125.00 | ₹151.10 | +17.13% | |
| ₹118.55 | ₹153.90 | ₹118.25 | ₹129.00 | +8.81% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Micro-cap hospital play; bet on execution, manage the downside.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Last major news was Q3FY26 results released on Feb 9, 2026, showing strong growth.
CORE STORY (THE REAL GAME)
Asarfi is a micro-cap play on the rising demand for healthcare in tier 2/3 cities. It's about capturing market share in a fragmented landscape, not disrupting the industry.
- Strong Q3 results
- Expansion into new geographies
- Upgrade to 'Buy' rating
- Successful expansion into Bihar/UP
- Significant order wins from government contracts
- Improved staff retention
- Micro-cap liquidity risk
- High reliance on government contracts & receivables
- High staff attrition
FII decreased holdings from 0.05% to 0.00% in Dec 2025 quarter. DII down 1.01%.
Rising healthcare demand in tier 2/3 cities is a tailwind.
Poor. Negative free cash flow of ₹-55.41 Cr over 5 years.
Next 3-6 months hinge on execution of expansion plans and maintaining growth momentum. Watch for Q4 results and any updates on new hospital projects.
Primary Thesis Risk
Failure to execute expansion plans will crater the stock.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Asarfi Hospital Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Asarfi Hospital Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ASARFI across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (18.98%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (18.77%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (19.82%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 25.64 vs Industry: 48.79)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (28.29%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (26.19% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (37.07% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (6.33x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (61.17%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Weak Earnings Growth (-21.34% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-56.31 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 2.97%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Asarfi Hospital Ltd vs Hospital Peers
Peer Comparison - Hospital
Compare Asarfi Hospital Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Asarfi Hospital LtdAsarfi Hospital...Selected✓ ASARFI • 543943 | 62.2/100 | ₹221.85₹222 | ₹437.92₹437.92 | 25.64Average 25.6 Average | 18.98%Good 18.98% Good | 18.77%Good 18.77% Good | 0.58Good 0.6 Good | 37.07%Excellent 37.07% Excellent | 26.19%Excellent 26.19% Excellent | 0.00% |
Apollo Hospitals Enterprise LtdApollo Hospital... APOLLOHOSP • 508869 | 62.1/100 | ₹8957.00₹8957 | ₹128448.55₹128448.55 | 65.68Average 65.7 Average | 22.11%Excellent 22.11% Excellent | 17.89%Good 17.89% Good | 0.90Good 0.9 Good | 77.79%Excellent 77.79% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LtdMax Healthcare ... MAXHEALTH • 543220 | 56.9/100 | ₹1098.50₹1099 | ₹107422.79₹107422.79 | 72.42Average 72.4 Average | 14.74%Average 14.74% Average | 14.71%Average 14.71% Average | 0.32Excellent 0.3 Excellent | 60.01%Excellent 60.01% Excellent | 27.27%Excellent 27.27% Excellent | 0.18% |
Fortis Healthcare LtdFortis Healthca... FORTIS • 532843 | 56.8/100 | ₹945.00₹945 | ₹73687.64₹73687.64 | 69.60Average 69.6 Average | 11.26%Average 11.26% Average | 13.47%Average 13.47% Average | 0.35Excellent 0.3 Excellent | 64.38%Excellent 64.38% Excellent | 17.76%Excellent 17.76% Excellent | 0.10% |
Aster DM Healthcare LtdAster DM Health... ASTERDM • 540975 | 37.2/100 | ₹822.15₹822 | ₹71917.90₹71917.90 | 176.20Average 176.2 Average | 10.70%Average 10.70% Average | 11.40%Average 11.40% Average | 0.49Excellent 0.5 Excellent | 22.57%Excellent 22.57% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Narayana Hrudayalaya LtdNarayana Hruday... NH • 539551 | 68.3/100 | ₹2029.20₹2029 | ₹41592.95₹41592.95 | 48.83Average 48.8 Average | 20.87%Excellent 20.87% Excellent | 15.36%Good 15.36% Good | 1.29Average 1.3 Average | 155.30%Excellent 155.30% Excellent | 25.04%Excellent 25.04% Excellent | 0.22% |
Global Health LtdGlobal Health L... MEDANTA • 543654 | 59.9/100 | ₹1405.60₹1406 | ₹35993.93₹35993.93 | 64.59Average 64.6 Average | 15.17%Good 15.17% Good | 17.14%Good 17.14% Good | 0.30Excellent 0.3 Excellent | 80.71%Excellent 80.71% Excellent | 24.97%Excellent 24.97% Excellent | 0.04% |
13.9/100 | ₹804.70₹805 | ₹33947.05₹33947.05 | 136.88Average 136.9 Average | 11.31%Average 11.31% Average | 9.29%Poor 9.29% Poor | 1.89Average 1.9 Average | 4.19%Average 4.19% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 48.5/100 | ₹478.00₹478 | ₹15618.15₹15618.15 | 117.89Average 117.9 Average | 6.81%Poor 6.81% Poor | 11.12%Average 11.12% Average | 0.53Good 0.5 Good | 34.42%Excellent 34.42% Excellent | 34.58%Excellent 34.58% Excellent | 0.00% |
Rainbow Childrens Medicare Pvt LtdRainbow Childre... RAINBOW • 543524 | 65.5/100 | ₹1525.40₹1525 | ₹15270.28₹15270.28 | 61.63Average 61.6 Average | 15.90%Good 15.90% Good | 17.35%Good 17.35% Good | 0.54Good 0.5 Good | 44.04%Excellent 44.04% Excellent | 21.24%Excellent 21.24% Excellent | 0.23% |
60/100 | ₹331.50₹332 | ₹9829.95₹9829.95 | 51.90Average 51.9 Average | 13.06%Average 13.06% Average | 14.80%Average 14.80% Average | 0.38Excellent 0.4 Excellent | 142.78%Excellent 142.78% Excellent | 25.27%Excellent 25.27% Excellent | 0.07% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Ltd share price128448.55 Cr
- Max Healthcare Institute Ltd share price107422.79 Cr
- Fortis Healthcare Ltd share price73687.64 Cr
- Aster DM Healthcare Ltd share price71917.90 Cr
- Narayana Hrudayalaya Ltd share price41592.95 Cr
Asarfi Hospital Ltd PE Ratio History
Historical price-to-earnings ratio for ASARFI — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹5.37 | ₹188.10 | 35x |
| FY 2024 | ₹2.31 | ₹99.75 | 43.2x |
| FY 2023 | ₹4.07 | ₹85.00 | 20.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Asarfi Hospital Ltd Quarterly Performance
Latest quarterly metrics for ASARFI — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
28.29%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
6.79%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
26.19%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
37.07%
Compounded annual net profit growth over 5 years
Asarfi Hospital Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ASARFI — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Asarfi Hospital Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Asarfi Hospital Ltd (ASARFI) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Asarfi Hospital Ltd
About ASARFI (Asarfi Hospital Ltd)
Asarfi Hospital Ltd is a beacon of healthcare accessibility nestled in the heart of Dhanbad, India. Established with a commitment to serve the local community, the hospital functio...ns as a multifaceted healthcare provider, exceeding the conventional boundaries of mere treatment. Asarfi distinguishes itself by emphasizing preventive care and health education, actively engaging with the population to foster a culture of well-being. From basic medical consultations to comprehensive health initiatives, the hospital strives to be the first point of contact for individuals seeking support on their journey to improved health. The organization's presence reflects a dedication to building a healthier future for the people it serves, prioritizing holistic care over a purely reactive approach to illness. Beyond its core medical services, Asarfi Hospital Ltd extends its reach through various community-focused programs. These initiatives include regular health camps designed to bring essential medical check-ups to underserved areas, along with crucial drug distribution programs to ensure medication access. The hospital also champions health and hygiene awareness, offering educational programs that promote healthy practices and prevent the spread of diseases. Recognizing the importance of holistic well-being, Asarfi incorporates yoga and exercise centers, allowing individuals to incorporate physical activity into their lifestyles. These diverse activities show their determination to impact the community. Asarfi Hospital Ltd acts as a health information resource for the people of Dhanbad and its surrounding areas. The hospital works to provide medical care, and also empowers individuals with the knowledge they need to make informed decisions about their health. By making preventative care a core principle, Asarfi Hospital Ltd is working to create a future where quality healthcare is available to everyone.
Company Details
Key Leadership
Latest News
ASARFI Share Price: Frequently Asked Questions
What is the current share price of Asarfi Hospital Ltd?
Asarfi Hospital Ltd (ASARFI) trades at ₹221.85 on NSE and BSE. Market cap ₹437.92 (Cr). Educational data only.
What is the P/E ratio of Asarfi Hospital Ltd?
Asarfi Hospital Ltd has a P/E of 25.64x vs industry average 48.79x.
What is the Bull Run score for Asarfi Hospital Ltd?
Asarfi Hospital Ltd has a Bull Run score of 62.2/100 based on 25+ financial parameters.
Does Asarfi Hospital Ltd pay dividends?
Asarfi Hospital Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Asarfi Hospital Ltd?
Asarfi Hospital Ltd has ROE of 18.98%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Asarfi Hospital Ltd?
Asarfi Hospital Ltd has debt-to-equity of 0.58.
Is Asarfi Hospital Ltd a good investment?
Bull Run gives Asarfi Hospital Ltd a score of 62.2/100. This is not investment advice — consult a SEBI-registered advisor.